SKI Market

Indian Indices

Nifty

24,967.75 97.65
(0.39%)

Sensex

80,981.06 -654.85
( -0.80%)

Bank Nifty

55,139.30 -10.10
( -0.02%)

Nifty IT

36,280.10 839.25
( 2.37%)

Global Indices

Nasdaq

45,305.71 -347.04
(-0.76%)

Dow Jones

6,460.93 -26.98
(-0.42%)

Hang Seng

42,789.96 156.67
(0.37%)

Nikkei 225

9,321.40 12.20
(0.13%)

Forex

USD-INR

87.34 0.17
(0.20%)

EUR-INR

102.37 0.98
(0.96%)

GBP-INR

118.09 0.93
(0.80%)

JPY-INR

0.59 0.00
(0.82%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Citurgia Biochemicals Ltd

Industry : Chemicals

BSE Code

ISIN Demat

Book Value()

506373

INE795B01031

-0.5292343

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CITURGIBIO

417.95

EPS(TTM)

Face Value()

Div & Yield %

Back

Relonchem receives UK MHRA approval for its products

Aug 18,2025

Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for the below-mentioned products from UK MHRA:

Metformin Hydrochloride Relonchem 500 mg Prolonged Release Tablets
Metformin Hydrochloride Relonchem 750 mg Prolonged Release Tablets
Metformin Hydrochloride Relonchem 1000 mg Prolonged Release Tablets

24,967.75 97.65 (0.39%)

80,981.06 -654.85 ( -0.80%)

55,139.30 -10.10 ( -0.02%)

36,280.10 839.25 ( 2.37%)

45,305.71 -347.04 (-0.76%)

6,460.93 -26.98 (-0.42%)

42,789.96 156.67 (0.37%)

9,321.40 12.20 (0.13%)

87.34 0.17 (0.20%)

102.37 0.98 (0.96%)

118.09 0.93 (0.80%)

0.59 0.00 (0.82%)